<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02552758</url>
  </required_header>
  <id_info>
    <org_study_id>2014-25</org_study_id>
    <nct_id>NCT02552758</nct_id>
  </id_info>
  <brief_title>The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism</brief_title>
  <official_title>The Influence of Omega-3 Fatty Acid on the Violence of Schizophrenia Patient and the Possible Mechanism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai Mental Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shanghai Mental Health Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigators plan to explore whether Omega-3 fatty acid have effect on the violent behavior
      of the schizophrenia patients. Investigators will use PET to explore the influence on
      serotonin function of the brain to understand the mechanism of how Omega-3 fatty acid works.
      This study will enroll 100 patients of schizophrenia with violent behavior.Participants will
      be split into two groups randomly. In one group, participants will receive one pill of
      placebo per day, and in the other, participants will have one pill of 900mg Omega-3 fatty
      acid per day. This intervention will last 3 months.At week 0, week 4, week 8 and week 12,
      some scales will be evaluated. Meanwhile, the density of eicosapentaenoic
      acid(EPA),docosahexaenoic acid (DHA),noradrenalin(NE), dopamine(DA) and serotonin(5-HT) in
      blood will be tested.At week 0 and week 12, 10 patients of each group will be randomly
      selected to have the exam of PET.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>violent behavior of Participants as Assessed by Modified Overt Aggression Scale(MOAS)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>change in violent behavior of participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>psychiatry symptoms of participants as assessed by Positive and Negative Syndrome Scale (PANSS)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>change in psychiatry symptoms of participants</description>
  </primary_outcome>
  <primary_outcome>
    <measure>blood level of eicosapentaenoic acid(EPA), docosahexaenoic acid (DHA), noradrenalin(NE), dopamine(DA) and serotonin(5-HT) of participants</measure>
    <time_frame>up to 24 months</time_frame>
    <description>change in the blood level of DHA, EPA, 5-HT, DA and NE at baseline, 4 weeks, 8 weeks and 12 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>the density of 5-HT1A receptor in brain tested by positron emission tomography (PET)</measure>
    <time_frame>up to 24 months</time_frame>
    <description>change of the density of 5-HT1A receptor in different groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Omega-3 fatty acid</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>omega-3 fatty acid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>omega-3 fatty acid</intervention_name>
    <description>omega-3 fatty acid</description>
    <arm_group_label>Omega-3 fatty acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>positron emission tomography (PET)</intervention_name>
    <arm_group_label>Omega-3 fatty acid</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  the sore of MOAS scale &gt;=4 more than 2 violent behavior in recent 6 months by self
             repot

        Exclusion Criteria:

          -  serious diseases,such as cardiovascular diseases,nervous system disease. allergy to
             fish oil
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Qiao, phD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shanghai Mental Health Center (China)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi Qiao, phD</last_name>
    <phone>+8613817615936</phone>
    <email>qiaoyi2004@msn.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai Mental Health Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200030</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Qiao, phD</last_name>
      <phone>+8613817615936</phone>
      <email>qiaoyi2004@msn.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2015</study_first_submitted>
  <study_first_submitted_qc>September 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 17, 2015</study_first_posted>
  <last_update_submitted>September 16, 2015</last_update_submitted>
  <last_update_submitted_qc>September 16, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>violence</keyword>
  <keyword>PET</keyword>
  <keyword>omega-3 fatty acid</keyword>
  <keyword>schizophrenia</keyword>
  <keyword>patient</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

